Intestinal-type sinonasal adenocarcinomas: The road to molecular diagnosis and personalized treatment

Ann Hoeben1, Linda van de Winkel2, Frank Hoebers3

  • 1Division of Medical Oncology, GROW - School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, The Netherlands. ann.hoeben@mumc.nl.

Head & Neck
|May 26, 2016
PubMed
Abstract

Insights

Sinonasal intestinal-type adenocarcinomas (ITACs) are rare nasal cancers linked to occupational dust exposure. Current treatments include surgery and radiotherapy, but systemic options for advanced ITAC require further research.

Area of Science:

  • Oncology
  • Head and Neck Cancer Research

Background:

  • Sinonasal intestinal-type adenocarcinomas (ITACs) are rare epithelial tumors.
  • Often associated with occupational exposure to organic dust (wood, leather).

Purpose of the Study:

  • To review current knowledge on ITAC.
  • To summarize histopathology, tumorigenesis, molecular characteristics, and treatment options.

Main Methods:

  • Literature review of scientific articles.
  • Databases searched include Pubmed, Medline, Cochrane, and Web of Science.

Main Results:

  • ITACs are rare cancers of the nasal cavity and sinuses.
  • Surgery is the primary treatment for resectable ITACs.
  • Postoperative radiotherapy improves local control; systemic treatments for advanced disease are less standardized.

Conclusions:

  • Further translational research is essential.
  • Identification of druggable targets is needed for personalized treatment.
  • Improved outcomes for advanced/metastatic ITAC patients require novel therapeutic strategies.